These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 29292466)
21. Azemi NA; Azemi AK; Abu-Bakar L; Sevakumaran V; Muhammad TST; Ismail N Mar Drugs; 2022 Dec; 20(12):. PubMed ID: 36547909 [No Abstract] [Full Text] [Related]
22. Inhibition of hepatic scavenger receptor-class B type I by RNA interference decreases atherosclerosis in rabbits. Demetz E; Tancevski I; Duwensee K; Stanzl U; Huber E; Heim C; Handle F; Theurl M; Schroll A; Tailleux A; Dietrich H; Patsch JR; Eller P; Ritsch A Atherosclerosis; 2012 Jun; 222(2):360-6. PubMed ID: 22494625 [TBL] [Abstract][Full Text] [Related]
23. Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages. Tsubakio-Yamamoto K; Matsuura F; Koseki M; Oku H; Sandoval JC; Inagaki M; Nakatani K; Nakaoka H; Kawase R; Yuasa-Kawase M; Masuda D; Ohama T; Maeda N; Nakagawa-Toyama Y; Ishigami M; Nishida M; Kihara S; Shimomura I; Yamashita S Biochem Biophys Res Commun; 2008 Oct; 375(3):390-4. PubMed ID: 18703020 [TBL] [Abstract][Full Text] [Related]
25. SR-BI as target in atherosclerosis and cardiovascular disease - A comprehensive appraisal of the cellular functions of SR-BI in physiology and disease. Hoekstra M Atherosclerosis; 2017 Mar; 258():153-161. PubMed ID: 28162236 [TBL] [Abstract][Full Text] [Related]
26. Restoration of high-density lipoprotein levels by cholesteryl ester transfer protein expression in scavenger receptor class B type I (SR-BI) knockout mice does not normalize pathologies associated with SR-BI deficiency. Hildebrand RB; Lammers B; Meurs I; Korporaal SJ; De Haan W; Zhao Y; Kruijt JK; Praticò D; Schimmel AW; Holleboom AG; Hoekstra M; Kuivenhoven JA; Van Berkel TJ; Rensen PC; Van Eck M Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1439-45. PubMed ID: 20431066 [TBL] [Abstract][Full Text] [Related]
28. Lipoprotein enhancement of ovarian theca-interstitial cell steroidogenesis: relative contribution of scavenger receptor class B (type I) and adenosine 5'-triphosphate- binding cassette (type A1) transporter in high-density lipoprotein-cholesterol transport and androgen synthesis. Wu Q; Sucheta S; Azhar S; Menon KM Endocrinology; 2003 Jun; 144(6):2437-45. PubMed ID: 12746305 [TBL] [Abstract][Full Text] [Related]
29. HDL and Scavenger Receptor Class B Type I (SRBI). Yu H Adv Exp Med Biol; 2022; 1377():79-93. PubMed ID: 35575922 [TBL] [Abstract][Full Text] [Related]
30. Identification of Novel Compounds Enhancing SR-BI mRNA Stability through High-Throughput Screening. Jia XJ; Du Y; Jiang HJ; Li YZ; Xu YN; Si SY; Wang L; Hong B SLAS Discov; 2020 Apr; 25(4):397-408. PubMed ID: 31858876 [TBL] [Abstract][Full Text] [Related]
31. ApoE promotes hepatic selective uptake but not RCT due to increased ABCA1-mediated cholesterol efflux to plasma. Annema W; Dikkers A; Freark de Boer J; Gautier T; Rensen PCN; Rader DJ; Tietge UJF J Lipid Res; 2012 May; 53(5):929-940. PubMed ID: 22383685 [TBL] [Abstract][Full Text] [Related]
32. Baicalin promotes cholesterol efflux by regulating the expression of SR-BI in macrophages. Yu R; Lv Y; Wang J; Pan N; Zhang R; Wang X; Yu H; Tan L; Zhao Y; Li B Exp Ther Med; 2016 Dec; 12(6):4113-4120. PubMed ID: 28105139 [TBL] [Abstract][Full Text] [Related]
33. Cholesteryl ester transfer protein expression partially attenuates the adverse effects of SR-BI receptor deficiency on cholesterol metabolism and atherosclerosis. El Bouhassani M; Gilibert S; Moreau M; Saint-Charles F; Tréguier M; Poti F; Chapman MJ; Le Goff W; Lesnik P; Huby T J Biol Chem; 2011 May; 286(19):17227-38. PubMed ID: 21454568 [TBL] [Abstract][Full Text] [Related]
34. EP 80317, a CD36 selective ligand, promotes reverse cholesterol transport in apolipoprotein E-deficient mice. Bujold K; Mellal K; Zoccal KF; Rhainds D; Brissette L; Febbraio M; Marleau S; Ong H Atherosclerosis; 2013 Aug; 229(2):408-14. PubMed ID: 23880196 [TBL] [Abstract][Full Text] [Related]
35. Localization and regulation of SR-BI in membrane rafts of HepG2 cells. Rhainds D; Bourgeois P; Bourret G; Huard K; Falstrault L; Brissette L J Cell Sci; 2004 Jul; 117(Pt 15):3095-105. PubMed ID: 15226391 [TBL] [Abstract][Full Text] [Related]
36. Hypocholesterolemia, foam cell accumulation, but no atherosclerosis in mice lacking ABC-transporter A1 and scavenger receptor BI. Zhao Y; Pennings M; Vrins CL; Calpe-Berdiel L; Hoekstra M; Kruijt JK; Ottenhoff R; Hildebrand RB; van der Sluis R; Jessup W; Le Goff W; Chapman MJ; Huby T; Groen AK; Van Berkel TJ; Van Eck M Atherosclerosis; 2011 Oct; 218(2):314-22. PubMed ID: 21840001 [TBL] [Abstract][Full Text] [Related]
37. SR-BI deficiency disassociates obesity from hepatic steatosis and glucose intolerance development in high fat diet-fed mice. Hoekstra M; Ouweneel AB; Price J; van der Geest R; van der Sluis RJ; Geerling JJ; Nahon JE; Van Eck M J Nutr Biochem; 2021 Mar; 89():108564. PubMed ID: 33321184 [TBL] [Abstract][Full Text] [Related]
38. Molecular mechanism of curcumin on the suppression of cholesterol accumulation in macrophage foam cells and atherosclerosis. Zhao JF; Ching LC; Huang YC; Chen CY; Chiang AN; Kou YR; Shyue SK; Lee TS Mol Nutr Food Res; 2012 May; 56(5):691-701. PubMed ID: 22648616 [TBL] [Abstract][Full Text] [Related]
39. Dihydrocapsaicin Attenuates Plaque Formation through a PPARγ/LXRα Pathway in apoE(-/-) Mice Fed a High-Fat/High-Cholesterol Diet. Hu YW; Ma X; Huang JL; Mao XR; Yang JY; Zhao JY; Li SF; Qiu YR; Yang J; Zheng L; Wang Q PLoS One; 2013; 8(6):e66876. PubMed ID: 23840542 [TBL] [Abstract][Full Text] [Related]
40. Scavenger receptor SR-BI in macrophage lipid metabolism. Ji A; Meyer JM; Cai L; Akinmusire A; de Beer MC; Webb NR; van der Westhuyzen DR Atherosclerosis; 2011 Jul; 217(1):106-12. PubMed ID: 21481393 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]